Regarding anti-cytokine agents for the treatment of epilepsy, the efficacy of using anti-IL-1 and anti-IL-6 to control seizures in drug-resistant epilepsy and refractory status epilepticus has been reviewed [22]. Here, IL1B is linked to epilepsy.